Aurinia Pharmaceuticals Inc.
AUPH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $83 | $49 | $94 | $232 |
| Short-Term Investments | $275 | $302 | $295 | $234 |
| Receivables | $37 | $24 | $13 | $15 |
| Inventory | $39 | $40 | $25 | $19 |
| Other Curr. Assets | $12 | $11 | $15 | $13 |
| Total Curr. Assets | $447 | $425 | $443 | $513 |
| Property Plant & Equip (Net) | $99 | $117 | $9 | $10 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $4 | $5 | $6 | $8 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $2 | $13 | $12 |
| Total NC Assets | $104 | $123 | $28 | $30 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $551 | $548 | $471 | $543 |
| Liabilities | – | – | – | – |
| Payables | $5 | $4 | $3 | $4 |
| Short-Term Debt | $15 | $16 | $1 | $1 |
| Tax Payable | $0 | $1 | $1 | $1 |
| Deferred Revenue | $11 | $5 | $3 | $0 |
| Other Curr. Liab. | $67 | $52 | $38 | $35 |
| Total Curr. Liab. | $98 | $77 | $46 | $41 |
| LT Debt | $64 | $82 | $7 | $8 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $11 | $11 | $12 | $16 |
| Total NC Liab. | $75 | $93 | $19 | $24 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $79 | $98 | $8 | $9 |
| Total Liabilities | $173 | $170 | $65 | $64 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1,188 | $1,200 | $1,185 | $1,177 |
| Retained Earnings | -$937 | -$942 | -$864 | -$756 |
| AOCI | -$1 | -$1 | -$1 | -$1 |
| Other Equity | $127 | $121 | $85 | $59 |
| Total Equity | $377 | $378 | $405 | $479 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $551 | $548 | $471 | $543 |
| Net Debt | -$4 | $49 | -$86 | -$223 |